Skip to main content

Guardian Pharmacy Services, Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

GRDN$47.02+10.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
(In thousands, except per share amounts)2025202620252026
Revenues$377,427$371,070$1,051,069$1,059,433
Cost of goods sold302,706285,847843,853817,857
Gross profit74,72185,223207,216241,576
Selling, general, and administrative expenses58,36760,160165,277178,194
Operating income16,35425,06341,93963,382
Other expenses (income):
Interest expense160177502485
Other expense (income), net(437)(1,091)(887)(11,165)
Total other expenses (income)(277)(914)(385)(10,680)
Income before income taxes16,63125,97742,32474,062
Provision for income taxes7,0386,85714,63119,277
Net income9,59319,12027,69354,785
Less net income (loss) attributable to non-controlling interests(225)440(603)938
Net income attributable to Guardian Pharmacy Services, Inc.$9,818$18,680$28,296$53,847
Basic$0.16$0.29$0.46$0.85
Diluted$0.15$0.29$0.45$0.84
Weighted-average Class A and Class B common shares outstanding
Basic62,12463,34362,07163,330
Diluted63,43263,91663,18063,813

1 See Note 7 - Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.